News & Perspective

Mar 01, 2011

Mar 01, 2011

HHS awards two contracts for recombinant flu vaccines

(CIDRAP News) – The US Department of Health and Human Services (HHS) yesterday announced that it has awarded $215 million in contracts to two companies to further the development of recombinant technology, a move designed to improve and speed production of pandemic and seasonal flu vaccines.

Mar 11, 2011

Mar 11, 2011

Study: Some trials overestimated flu vaccine efficacy

(CIDRAP News) – Researchers from the University of Michigan say one measure of flu vaccine efficacy that has been used in a number of past controlled trials is not very accurate, and that this may have led to a degree of overselling of the protection the vaccines provide.

Mar 16, 2011

Mar 16, 2011

HHS: 386 injury claims filed over H1N1 countermeasures

Editor's note: This story was revised Mar 17 to include additional information about the number of claims filed and processing steps.

(CIDRAP News) – The US Department of Health and Human Services (HHS) has so far received 386 claims of injuries related to the 2009 pandemic H1N1 vaccine and related pandemic countermeasures, HHS officials reported today.

Mar 21, 2011

Mar 21, 2011

Preliminary studies show lower flu-shot effectiveness in Europe

(CIDRAP News) – Preliminary studies suggest that this year's trivalent seasonal flu vaccine used in Europe was less effective against the 2009 H1N1 virus than last year's monovalent H1N1 vaccine was, possibly because of some degree of mutation in the virus, according to recent reports in Eurosurveillance.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»